SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-308649
Filing Date
2019-12-09
Accepted
2019-12-09 06:45:03
Documents
3
Period of Report
2019-12-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d834130d8k.htm 8-K 18748
2 EX-99.1 d834130dex991.htm EX-99.1 21101
3 EX-99.2 d834130dex992.htm EX-99.2 18333
  Complete submission text file 0001193125-19-308649.txt   59348
Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38938 | Film No.: 191274289
SIC: 2834 Pharmaceutical Preparations